These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20943766)

  • 1. VEGF-modified human embryonic mesenchymal stem cell implantation enhances protection against cisplatin-induced acute kidney injury.
    Yuan L; Wu MJ; Sun HY; Xiong J; Zhang Y; Liu CY; Fu LL; Liu DM; Liu HQ; Mei CL
    Am J Physiol Renal Physiol; 2011 Jan; 300(1):F207-18. PubMed ID: 20943766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice.
    Morigi M; Introna M; Imberti B; Corna D; Abbate M; Rota C; Rottoli D; Benigni A; Perico N; Zoja C; Rambaldi A; Remuzzi A; Remuzzi G
    Stem Cells; 2008 Aug; 26(8):2075-82. PubMed ID: 18499895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor-1 sustains stem cell mediated renal repair.
    Imberti B; Morigi M; Tomasoni S; Rota C; Corna D; Longaretti L; Rottoli D; Valsecchi F; Benigni A; Wang J; Abbate M; Zoja C; Remuzzi G
    J Am Soc Nephrol; 2007 Nov; 18(11):2921-8. PubMed ID: 17942965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury.
    Tögel F; Weiss K; Yang Y; Hu Z; Zhang P; Westenfelder C
    Am J Physiol Renal Physiol; 2007 May; 292(5):F1626-35. PubMed ID: 17213465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human marrow-derived mesenchymal stromal cells decrease cisplatin renotoxicity in vitro and in vivo and enhance survival of mice post-intraperitoneal injection.
    Eliopoulos N; Zhao J; Bouchentouf M; Forner K; Birman E; Yuan S; Boivin MN; Martineau D
    Am J Physiol Renal Physiol; 2010 Dec; 299(6):F1288-98. PubMed ID: 20844023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Life-sparing effect of human cord blood-mesenchymal stem cells in experimental acute kidney injury.
    Morigi M; Rota C; Montemurro T; Montelatici E; Lo Cicero V; Imberti B; Abbate M; Zoja C; Cassis P; Longaretti L; Rebulla P; Introna M; Capelli C; Benigni A; Remuzzi G; Lazzari L
    Stem Cells; 2010 Mar; 28(3):513-22. PubMed ID: 20049901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction.
    Deuse T; Peter C; Fedak PW; Doyle T; Reichenspurner H; Zimmermann WH; Eschenhagen T; Stein W; Wu JC; Robbins RC; Schrepfer S
    Circulation; 2009 Sep; 120(11 Suppl):S247-54. PubMed ID: 19752375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal-like progenitors derived from human embryonic stem cells promote recovery from acute kidney injury via paracrine actions.
    Luo J; Zhao X; Tan Z; Su Z; Meng F; Zhang M
    Cytotherapy; 2013 Jun; 15(6):649-62. PubMed ID: 23415919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury.
    Gatti S; Bruno S; Deregibus MC; Sordi A; Cantaluppi V; Tetta C; Camussi G
    Nephrol Dial Transplant; 2011 May; 26(5):1474-83. PubMed ID: 21324974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human adipose tissue-derived mesenchymal stem cells protect kidneys from cisplatin nephrotoxicity in rats.
    Kim JH; Park DJ; Yun JC; Jung MH; Yeo HD; Kim HJ; Kim DW; Yang JI; Lee GW; Jeong SH; Roh GS; Chang SH
    Am J Physiol Renal Physiol; 2012 May; 302(9):F1141-50. PubMed ID: 22205231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal vascular endothelial growth factor in neonatal obstructive nephropathy. II. Exogenous VEGF.
    Burt LE; Forbes MS; Thornhill BA; Kiley SC; Minor JJ; Chevalier RL
    Am J Physiol Renal Physiol; 2007 Jan; 292(1):F168-74. PubMed ID: 16788139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor A contributes to glioma-induced migration of human marrow stromal cells (hMSC).
    Schichor C; Birnbaum T; Etminan N; Schnell O; Grau S; Miebach S; Aboody K; Padovan C; Straube A; Tonn JC; Goldbrunner R
    Exp Neurol; 2006 Jun; 199(2):301-10. PubMed ID: 16574102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human umbilical cord mesenchymal stem cells attenuate cisplatin-induced acute and chronic renal injury.
    Peng X; Xu H; Zhou Y; Wang B; Yan Y; Zhang X; Wang M; Gao S; Zhu W; Xu W; Qian H
    Exp Biol Med (Maywood); 2013 Aug; 238(8):960-70. PubMed ID: 23970411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stromal cells protect against acute tubular injury via an endocrine effect.
    Bi B; Schmitt R; Israilova M; Nishio H; Cantley LG
    J Am Soc Nephrol; 2007 Sep; 18(9):2486-96. PubMed ID: 17656474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection.
    Herrmann JL; Wang Y; Abarbanell AM; Weil BR; Tan J; Meldrum DR
    Shock; 2010 Jan; 33(1):24-30. PubMed ID: 19996917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms.
    Tögel F; Hu Z; Weiss K; Isaac J; Lange C; Westenfelder C
    Am J Physiol Renal Physiol; 2005 Jul; 289(1):F31-42. PubMed ID: 15713913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic benefits of angiogenetic gene-modified human mesenchymal stem cells after cerebral ischemia.
    Toyama K; Honmou O; Harada K; Suzuki J; Houkin K; Hamada H; Kocsis JD
    Exp Neurol; 2009 Mar; 216(1):47-55. PubMed ID: 19094989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VEGF improves survival of mesenchymal stem cells in infarcted hearts.
    Pons J; Huang Y; Arakawa-Hoyt J; Washko D; Takagawa J; Ye J; Grossman W; Su H
    Biochem Biophys Res Commun; 2008 Nov; 376(2):419-22. PubMed ID: 18789891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPAR-alpha ligand ameliorates acute renal failure by reducing cisplatin-induced increased expression of renal endonuclease G.
    Li S; Basnakian A; Bhatt R; Megyesi J; Gokden N; Shah SV; Portilla D
    Am J Physiol Renal Physiol; 2004 Nov; 287(5):F990-8. PubMed ID: 15280156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glial cell line-derived neurotrophic growth factor increases motility and survival of cultured mesenchymal stem cells and ameliorates acute kidney injury.
    Shi H; Patschan D; Dietz GP; Bähr M; Plotkin M; Goligorsky MS
    Am J Physiol Renal Physiol; 2008 Jan; 294(1):F229-35. PubMed ID: 18003856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.